This is a preview of subscription content, log in via an institution to check access.
Reference
Lo AO, et al. Cost-effectiveness of the highly effective direct-acting antivirals in the treatment of chronic hepatitis C in Hong Kong. Journal of Gastroenterology and Hepatology 32: 1071-1078, No. 5, May 2017. Available from: URL: http://doi.org/10.1111/jgh.13638
Rights and permissions
About this article
Cite this article
"Desirable cost" of new DAAs in CHC treatment in Hong Kong. PharmacoEcon Outcomes News 778, 10 (2017). https://doi.org/10.1007/s40274-017-3987-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3987-7